For the treatment of breast carcinoma: Oral Adults: 100 mg/ml PO on days 1-14. 1,V Dosage: Adults: 400—600 mg/min IV on day 1
Lung carcinoma: I.V. Dosage: Adults: 750—1000 mg/m IV on day 1.
Oarian carcinoma:I.V. Dose Adults: 300—1000 mg/minut IV on day 1. Oral Dosage: Adults: 150 mg/ml PO once daily for 14 days. Chronic lymphocytic leukemia (CLL): Oral Dosage: Adults: 300 mg/ml PO once daily for 5 days. Multiple myeloma I.V. Dosage: Adults: 400 mg/min IV on day 1. Soft-tissue sarcoma: I.V. Dosage: 500 mgtminute up to 1000 mg/minute.
Vial
210 EGP
For the treatment of breast carcinoma: Oral Adults: 100 mg/ml PO on days 1-14. 1,V Dosage: Adults: 400—600 mg/min IV on day 1
Lung carcinoma: I.V. Dosage: Adults: 750—1000 mg/m IV on day 1.
Oarian carcinoma:I.V. Dose Adults: 300—1000 mg/minut IV on day 1. Oral Dosage: Adults: 150 mg/ml PO once daily for 14 days. Chronic lymphocytic leukemia (CLL): Oral Dosage: Adults: 300 mg/ml PO once daily for 5 days. Multiple myeloma I.V. Dosage: Adults: 400 mg/min IV on day 1. Soft-tissue sarcoma: I.V. Dosage: 500 mgtminute up to 1000 mg/minute.
Note: All the provided information about this drug does not substitute for consulting a doctor.